The benefits of measuring the size and number of lipoprotein particles for cardiovascular risk prediction: A systematic review and meta-analysis Jose A. Quesada; Vicente Bertomeu-González; Domingo Orozco-Beltrán; Alberto Cordero; Vicente F. Gil-Guillén; Adriana López-Pineda; Rauf Nouni-García; Concepción Carratalá-Munuera;

Approach to the cardiometabolic continuum. Narrative description J. Ildefonzo Arocha Rodulfo;

Efficacy and safety of PCSK9 inhibitors in real life Antón González-Guerrero; Eugenia Navarrete-Rouco; David Benaiges; Eva Giralt-Steinhauer; Lidia Marcos; Anna Oliveras; Lluis Recasens; Juan Pedro-Botet;